Structural Formula (Pos04 0007 01)
Posluma Injection
Product Images NDC 69932-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Posluma (NDC 69932-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Blue Earth Diagnostics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Blue Earth Diagnostics Logo (Pos04 0007 02)
Principal Display Panel – 50 mL Vial Label (Pos04 0007 03)
Posluma® is a sterile non-pyrogenic diagnostic injection used only for intravenous use. It contains flotufolastat, with a concentration ranging from 296 MBg/mL to 5,846 MBg/mL at the end of the synthesis. Each mL also contains up to 20 meg of flotufolastat gallium, less than 10% alcohol, anhydrous citric acid, sodium chloride, and sodium hydroxide. It has a shelf life of 10 hours after synthesis, and it is a radioactive material that must be shielded and stored between 20°C to 25°C. The correct dose can be calculated from the end of the synthesis, and users should not use it if the solution is discolored or contains particulate matter. This product is manufactured by PETNET Solutions and is exclusively for use by Blue Earth Diagnostics.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
